IL10 and acute myeloid leukemia: Regarding IL‐10 rs1800896, our findings were in line with those of Fei et al who found no significant differences between AML patients and controls when comparing rs1800896 allele and genotype frequencies.35 Hiroki et al observed no association between the IL‐10 rs1800896 variant genotype and IL‐10 plasma levels and concluded that rs1800896 was not associated with acute lymphoblastic leukemia (ALL) susceptibility nor with relapse risk.11